Annual EBIT
-$34.12 M
+$31.35 M+47.89%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual earnings before interest & taxes is -$34.12 million, with the most recent change of +$31.35 million (+47.89%) on December 31, 2022.
- During the last 3 years, ELOX annual EBIT has risen by +$15.14 million (+30.74%).
Performance
ELOX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.36 M
+$754.00 K+18.34%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly earnings before interest & taxes is -$3.36 million, with the most recent change of +$754.00 thousand (+18.34%) on September 30, 2023.
- Over the past year, ELOX quarterly EBIT has increased by +$3.66 million (+52.17%).
- ELOX quarterly EBIT is now -286.98% below its all-time high of $1.80 million, reached on June 30, 2010.
Performance
ELOX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$18.95 M
+$3.66 M+16.19%
September 30, 2023
Summary
- As of February 8, 2025, ELOX TTM earnings before interest & taxes is -$18.95 million, with the most recent change of +$3.66 million (+16.19%) on September 30, 2023.
- Over the past year, ELOX TTM EBIT has increased by +$21.08 million (+52.66%).
- ELOX TTM EBIT is now -4637.75% below its all-time high of -$400.00 thousand, reached on December 31, 1999.
Performance
ELOX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ELOX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.9% | +52.2% | +52.7% |
| 3 y3 years | +30.7% | +46.6% | +50.9% |
| 5 y5 years | -61.1% | +76.0% | +61.5% |
ELOX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +47.9% | at high | +71.1% | at high | +72.2% |
| 5 y | 5-year | -2.9% | +47.9% | at high | +90.6% | at high | +72.2% |
| alltime | all time | <-9999.0% | +47.9% | -287.0% | +90.6% | -4637.8% | +72.2% |
Eloxx Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$3.36 M(-18.3%) | -$18.95 M(-16.2%) |
| Jun 2023 | - | -$4.11 M(-28.4%) | -$22.61 M(-21.1%) |
| Mar 2023 | - | -$5.75 M(+0.1%) | -$28.67 M(-16.0%) |
| Dec 2022 | -$34.12 M(-47.9%) | -$5.74 M(-18.3%) | -$34.14 M(-14.7%) |
| Sep 2022 | - | -$7.02 M(-30.9%) | -$40.03 M(-6.2%) |
| Jun 2022 | - | -$10.16 M(-9.4%) | -$42.67 M(-37.5%) |
| Mar 2022 | - | -$11.22 M(-3.6%) | -$68.25 M(+4.2%) |
| Dec 2021 | -$65.47 M(+97.4%) | -$11.63 M(+20.4%) | -$65.47 M(+9.8%) |
| Sep 2021 | - | -$9.66 M(-73.0%) | -$59.64 M(+6.0%) |
| Jun 2021 | - | -$35.74 M(+323.7%) | -$56.27 M(+100.5%) |
| Mar 2021 | - | -$8.43 M(+45.2%) | -$28.07 M(-15.4%) |
| Dec 2020 | -$33.17 M(-32.7%) | -$5.81 M(-7.7%) | -$33.17 M(-14.0%) |
| Sep 2020 | - | -$6.29 M(-16.6%) | -$38.56 M(-13.7%) |
| Jun 2020 | - | -$7.54 M(-44.3%) | -$44.70 M(-12.6%) |
| Mar 2020 | - | -$13.53 M(+20.8%) | -$51.13 M(+3.7%) |
| Dec 2019 | -$49.26 M(+4.7%) | -$11.20 M(-9.9%) | -$49.29 M(-5.3%) |
| Sep 2019 | - | -$12.43 M(-11.0%) | -$52.06 M(+2.5%) |
| Jun 2019 | - | -$13.97 M(+19.4%) | -$50.77 M(+0.5%) |
| Mar 2019 | - | -$11.70 M(-16.3%) | -$50.52 M(+11.5%) |
| Dec 2018 | -$47.06 M(+122.3%) | -$13.97 M(+25.5%) | -$45.31 M(+44.6%) |
| Sep 2018 | - | -$11.14 M(-18.8%) | -$31.34 M(+46.8%) |
| Jun 2018 | - | -$13.71 M(+111.2%) | -$21.34 M(+69.5%) |
| Mar 2018 | - | -$6.49 M(+469.8%) | -$12.59 M(+81.2%) |
| Dec 2017 | -$21.17 M(+222.2%) | - | - |
| Sep 2017 | - | -$1.14 M(-77.0%) | -$6.95 M(-5.9%) |
| Jun 2017 | - | -$4.96 M(+1351.2%) | -$7.38 M(-11.6%) |
| Jun 2017 | -$6.57 M(-26.6%) | - | - |
| Mar 2017 | - | -$341.90 K(-32.6%) | -$8.35 M(-6.3%) |
| Dec 2016 | - | -$507.50 K(-67.7%) | -$8.92 M(-4.8%) |
| Sep 2016 | - | -$1.57 M(-73.5%) | -$9.37 M(+4.7%) |
| Jun 2016 | -$8.95 M(-50.5%) | -$5.93 M(+553.0%) | -$8.95 M(-37.6%) |
| Mar 2016 | - | -$908.10 K(-5.2%) | -$14.33 M(-2.2%) |
| Dec 2015 | - | -$958.10 K(-16.8%) | -$14.65 M(-10.2%) |
| Sep 2015 | - | -$1.15 M(-89.8%) | -$16.32 M(-9.7%) |
| Jun 2015 | -$18.06 M(+97.4%) | -$11.32 M(+823.8%) | -$18.06 M(+70.3%) |
| Mar 2015 | - | -$1.23 M(-53.3%) | -$10.61 M(-7.9%) |
| Dec 2014 | - | -$2.63 M(-9.3%) | -$11.51 M(+9.9%) |
| Sep 2014 | - | -$2.89 M(-25.1%) | -$10.47 M(+14.5%) |
| Jun 2014 | -$9.15 M(+52.4%) | -$3.86 M(+81.4%) | -$9.15 M(+18.8%) |
| Mar 2014 | - | -$2.13 M(+34.0%) | -$7.70 M(+16.4%) |
| Dec 2013 | - | -$1.59 M(+1.4%) | -$6.61 M(+4.6%) |
| Sep 2013 | - | -$1.57 M(-35.0%) | -$6.32 M(+5.4%) |
| Jun 2013 | -$6.00 M(+17.9%) | -$2.41 M(+131.1%) | -$6.00 M(+24.1%) |
| Mar 2013 | - | -$1.04 M(-19.7%) | -$4.84 M(-1.3%) |
| Dec 2012 | - | -$1.30 M(+4.3%) | -$4.90 M(-3.1%) |
| Sep 2012 | - | -$1.25 M(+0.1%) | -$5.06 M(+4.9%) |
| Jun 2012 | -$5.09 M(-16.4%) | -$1.25 M(+12.3%) | -$4.82 M(-6.7%) |
| Mar 2012 | - | -$1.11 M(-23.9%) | -$5.16 M(-5.1%) |
| Dec 2011 | - | -$1.46 M(+44.4%) | -$5.44 M(+6.8%) |
| Sep 2011 | - | -$1.01 M(-36.6%) | -$5.09 M(-16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | -$6.09 M(+25.6%) | -$1.59 M(+14.9%) | -$6.08 M(+125.6%) |
| Mar 2011 | - | -$1.38 M(+24.7%) | -$2.70 M(-58.2%) |
| Dec 2010 | - | -$1.11 M(-44.4%) | -$6.44 M(-6.0%) |
| Sep 2010 | - | -$2.00 M(-211.2%) | -$6.85 M(+17.4%) |
| Jun 2010 | -$4.85 M(+13.1%) | $1.80 M(-135.0%) | -$5.84 M(-34.1%) |
| Mar 2010 | - | -$5.13 M(+237.3%) | -$8.86 M(+87.4%) |
| Dec 2009 | - | -$1.52 M(+54.6%) | -$4.73 M(+6.6%) |
| Sep 2009 | - | -$983.70 K(-19.7%) | -$4.43 M(+3.5%) |
| Jun 2009 | -$4.28 M(+19.1%) | -$1.22 M(+22.7%) | -$4.28 M(+5.9%) |
| Mar 2009 | - | -$997.70 K(-18.8%) | -$4.04 M(-6.4%) |
| Dec 2008 | - | -$1.23 M(+47.2%) | -$4.32 M(+6.3%) |
| Sep 2008 | - | -$834.30 K(-15.3%) | -$4.06 M(+12.9%) |
| Jun 2008 | -$3.60 M(+8.4%) | -$984.50 K(-22.6%) | -$3.60 M(+7.8%) |
| Mar 2008 | - | -$1.27 M(+30.9%) | -$3.34 M(+15.6%) |
| Dec 2007 | - | -$971.90 K(+162.2%) | -$2.89 M(-6.2%) |
| Sep 2007 | - | -$370.70 K(-48.9%) | -$3.08 M(-7.2%) |
| Jun 2007 | -$3.32 M(-2.9%) | -$725.60 K(-11.7%) | -$3.32 M(-2.4%) |
| Mar 2007 | - | -$822.20 K(-29.2%) | -$3.40 M(+2.4%) |
| Dec 2006 | - | -$1.16 M(+90.0%) | -$3.32 M(+7.1%) |
| Sep 2006 | - | -$611.40 K(-24.2%) | -$3.10 M(-9.3%) |
| Jun 2006 | -$3.42 M(+2.9%) | -$806.10 K(+8.6%) | -$3.42 M(-1.6%) |
| Mar 2006 | - | -$742.00 K(-21.2%) | -$3.47 M(-4.9%) |
| Dec 2005 | - | -$941.70 K(+1.3%) | -$3.65 M(+3.8%) |
| Sep 2005 | - | -$929.50 K(+8.1%) | -$3.52 M(+6.0%) |
| Jun 2005 | -$3.32 M(-17.7%) | -$860.00 K(-6.7%) | -$3.32 M(-14.5%) |
| Mar 2005 | - | -$922.00 K(+14.1%) | -$3.88 M(+8.7%) |
| Dec 2004 | - | -$808.20 K(+10.5%) | -$3.57 M(-2.5%) |
| Sep 2004 | - | -$731.50 K(-48.5%) | -$3.66 M(-15.7%) |
| Jun 2004 | -$4.04 M(+78.0%) | -$1.42 M(+132.9%) | -$4.34 M(+27.4%) |
| Mar 2004 | - | -$610.50 K(-32.1%) | -$3.41 M(+2.4%) |
| Dec 2003 | - | -$898.70 K(-36.3%) | -$3.33 M(+5.9%) |
| Sep 2003 | - | -$1.41 M(+189.7%) | -$3.14 M(+38.5%) |
| Jun 2003 | -$2.27 M(+7.3%) | -$487.20 K(-8.4%) | -$2.27 M(+5.5%) |
| Mar 2003 | - | -$532.10 K(-25.3%) | -$2.15 M(+1.7%) |
| Dec 2002 | - | -$712.10 K(+32.6%) | -$2.11 M(-1.8%) |
| Sep 2002 | - | -$537.20 K(+45.3%) | -$2.15 M(+1.9%) |
| Jun 2002 | -$2.11 M(+7.3%) | -$369.60 K(-25.4%) | -$2.11 M(-2.1%) |
| Mar 2002 | - | -$495.50 K(-34.1%) | -$2.16 M(+2.0%) |
| Dec 2001 | - | -$751.40 K(+51.0%) | -$2.12 M(+8.9%) |
| Sep 2001 | - | -$497.70 K(+19.8%) | -$1.95 M(-1.3%) |
| Jun 2001 | -$1.97 M(-19.5%) | -$415.60 K(-8.4%) | -$1.97 M(-9.6%) |
| Mar 2001 | - | -$453.90 K(-21.6%) | -$2.18 M(-14.6%) |
| Dec 2000 | - | -$579.00 K(+10.8%) | -$2.55 M(+7.5%) |
| Sep 2000 | - | -$522.60 K(-16.4%) | -$2.38 M(+28.2%) |
| Jun 2000 | -$2.45 M(+111.7%) | -$625.30 K(-24.4%) | -$1.85 M(+50.9%) |
| Mar 2000 | - | -$827.40 K(+106.8%) | -$1.23 M(+206.8%) |
| Dec 1999 | - | -$400.00 K | -$400.00 K |
| Jun 1999 | -$1.16 M(<-9900.0%) | - | - |
| Jun 1998 | $0.00(0.0%) | - | - |
| Jun 1997 | $0.00 | - | - |
FAQ
- What is Eloxx Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual EBIT year-on-year change?
- What is Eloxx Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly EBIT year-on-year change?
- What is Eloxx Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals TTM EBIT year-on-year change?
What is Eloxx Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ELOX is -$34.12 M
What is the all time high annual EBIT for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual earnings before interest & taxes is $0.00
What is Eloxx Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ELOX annual earnings before interest & taxes has changed by +$31.35 M (+47.89%)
What is Eloxx Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ELOX is -$3.36 M
What is the all time high quarterly EBIT for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly earnings before interest & taxes is $1.80 M
What is Eloxx Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ELOX quarterly earnings before interest & taxes has changed by +$3.66 M (+52.17%)
What is Eloxx Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ELOX is -$18.95 M
What is the all time high TTM EBIT for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high TTM earnings before interest & taxes is -$400.00 K
What is Eloxx Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ELOX TTM earnings before interest & taxes has changed by +$21.08 M (+52.66%)